SEC Form D · Amendment · filed December 16, 2021
Aro Biotherapeutics Co
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (32)
Susan B. Dillon · Philadelphia, PAExec · DirectorChristopher B. Mirabelli · Philadelphia, PADirectorKevin B. Raidy · Philadelphia, PADirectorMarten B. Steen · Philadelphia, PADirectorJess B. Lifton · Philadelphia, PADirectorKaryn B. O'Neil · Philadelphia, PAExec · DirectorElizabeth B. Anderson · Philadelphia, PADirectorMark B. Laurenzi · Philadelphia, PAExecBruce B. Peacock · Philadelphia, PADirectorScott B. Greenberg · Philadelphia, PAExecJames A. Mish · BUFFALO, NYExecMichael A. Zercher · BUFFALO, NYDirectorJamie S. Haggard · Fort Collins, COExec · DirectorCharles R. Conn · Oxford, United KingdomDirectorRoger D. O'Brien · BUFFALO, NYDirectorSteve S. Deitsch · Fort Collins, COExecSteven A. Przybyla · BUFFALO, NYDirectorJohn A. Franzino · BUFFALO, NYDirectorMatthew S. Thompson · Fort Collins, CODirectorKevin C. Smith · Denver, COExec · DirectorDaniel B. Janse · Philadelphia, PADirectorCraig Dickman · GREEN BAY, WIDirectorBob Vruggink · STEAMBOAT SPRINGS, COExecTyler Ellison · EGG HARBOR, WIExec · DirectorBill Butler · LOS ANGELES, CAExec · DirectorC. D. Adair · Nashville, TNDirectorHeidi Ridley · Orinda, CADirectorPatricia K. Salame · Oklahoma City, OKDirectorAlfredo Marti · Stamford, CTDirectorJoshua Goldberg · Baltimore, MDDirectorKenneth Ryan · Stamford, CTExecDaniel B. Janse · Philadelphia, PADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗